Home » Topics » Conferences

Conferences
RSS

Combination immunotherapy of renal cell carcinoma: efficacy established in phase II trial

June 11, 1998

Excellent phase III results reported for bropirimine in CIS

June 11, 1998

Vapreotide, RC-3940-II and cetrorelix: novel peptide analogues for treating renal cell carcinoma

June 11, 1998

New and established treatments for BPH reviewed at AUA

June 10, 1998

Efficacy of Ginkgo biloba extract in ED disproved in controlled clinical trial

June 8, 1998

Targeted NO donor enhances the activity of aspirin and heparin in preventing embolization

June 8, 1998

BRAINS: a phase II trial of Bay-x-3702 in ischemic stroke

June 8, 1998

Gavestinel enters phase III; good phase II results in acute stroke reported

June 8, 1998

Preclinical and clinical profile of lercanidipine detailed at recent congress

June 5, 1998

Cardioprotective properties found for pranidipine, a long-acting Ca antagonist

June 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...